Literature DB >> 17270636

Modified perianal/pericapsular anesthesia for transrectal biopsy of prostate in patients with anal rectal problems.

Sergey Kravchick1, Boris Yoffe, Shmuel Cytron.   

Abstract

OBJECTIVES: To modify our technique of perianal anesthesia and use it in patients with painful conditions of the rectum and/or anus.
METHODS: A total of 31 consecutive patients with anal-rectal problems underwent prostate needle biopsy. Of these, 17 were referred to our hospital after vain attempts to insert a transrectal ultrasound probe. Patients received a perianal-pericapsular injection of 1% lidocaine. Pain perception was separately assessed for probe insertion and biopsies using a visual pain analog score.
RESULTS: Only in 1 patient were we unable to insert the transrectal ultrasound probe. The mean patient age was 65.28 +/- 5.35 years. We performed a mean of 12.25 biopsies per case. At probe insertion, the mean pain score was 2.2 +/- 0.83. During the biopsy punctures, the mean pain level was 2.53 +/- 1.054. We did not find any increase in the complication rate related to the anesthesia method.
CONCLUSIONS: Modified perianal anesthesia can be used for transrectal ultrasound-guided biopsy of the prostate in patients with anal-rectal problems, because it provides significant pain relief.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17270636     DOI: 10.1016/j.urology.2006.09.016

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  2 in total

1.  Comparative evaluation of bilateral pudendal nerve blockade and periprostatic nerve block in transrectal ultrasound guided prostate biopsy: a prospective randomised trial.

Authors:  Rahmi Aslan; Akif Erbin; Recep Eryilmaz; Kerem Taken
Journal:  Cent European J Urol       Date:  2020-06-19

2.  Utility of a herpes oncolytic virus for the detection of neural invasion by cancer.

Authors:  Ziv Gil; Kaitlyn J Kelly; Peter Brader; Jatin P Shah; Yuman Fong; Richard J Wong
Journal:  Neoplasia       Date:  2008-04       Impact factor: 5.715

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.